Form 8-K - Current report:
SEC Accession No. 0001104659-24-132925
Filing Date
2024-12-31
Accepted
2024-12-31 17:23:55
Documents
18
Period of Report
2024-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2432248d2_8k.htm   iXBRL 8-K 40582
2 EXHIBIT 4.1 tm2432248d2_ex4-1.htm EX-4.1 96753
3 EXHIBIT 4.2 tm2432248d2_ex4-2.htm EX-4.2 108439
4 EXHIBIT 10.1 tm2432248d2_ex10-1.htm EX-10.1 187572
5 EXHIBIT 10.2 tm2432248d2_ex10-2.htm EX-10.2 38328
6 EXHIBIT 99.1 tm2432248d2_ex99-1.htm EX-99.1 15875
  Complete submission text file 0001104659-24-132925.txt   788415

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tmb-20241229.xsd EX-101.SCH 3012
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20241229_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20241229_pre.xml EX-101.PRE 22358
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2432248d2_8k_htm.xml XML 3597
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 241593828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)